Stanford University
Showing 801-850 of 2,212 Results
-
Sharon Wei Hung
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr Sharon Hung is a board-certified Internal Medicine physician who practices at the Stanford Internal Medicine Clinic in Santa Clara.
She received her MD degree at Northwestern Feinberg School of Medicine and completed her internal medicine residency training at Cedars-Sinai Medical Center.
Prior to working at Stanford, she was on faculty at the University of Arizona College of Medicine.
Currently, her clinical interests include both preventative medicine as well as managing chronic medical conditions such as diabetes, osteoporosis and steatotic liver disease.
She is the Director of Women’s Health for the Primary Care and Population Health department. Under this role, she is the course director of Stanford CME's Women's Health conference and the host for the Stanford CME's Women's Health vodcast which can be found on YouTube.
She offers group patient visits for counseling on osteoporosis and creates educational resources for primary care providers on various women’s health topics.
She is conversational in Spanish and Mandarin. -
Jennifer L. Hunter, PA-C
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioJennifer Hunter, PA-C is the Lead Advanced Practice Provider (APP) for the Emergency Department & Clinical Decision Unit (CDU) with experience in Adult Congenital Heart Disease (ACHD) and over 10 years of experience in Emergency Medicine. She is also a Clinical Assistant Professor and Educator-4-Care (E4C) at the Stanford School of Medicine & Masters of Science in PA Studies Program.
-
Zepeng Huo
Postdoctoral Scholar, Biomedical Informatics
BioConducting research on Foundation Models for medicine
-
Yusra Hussain, M.D.
Adjunct Clinical Assistant Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly InterestsCollaborator in the HALF study
Collaborator in the PROMISE study
Primary Investigator, Bidet Pilot Study- 650-644-9230 -
Elizabeth W Hwang
Clinical Associate Professor (Affiliated), Medicine - Med/Gastroenterology and Hepatology
Staff, Medicine - Med/Gastroenterology and HepatologyBioBoard Certification
Transplant Hepatology
Gastroenterology
Internal Medicine
Professional Education
Fellowship: Stanford University School of Medicine, Gastroenterology and Hepatology (2012)
Fellowship: Columbia University Medical Center, Transplant Hepatology (2009)
Residency: Columbia University Medical Center, Internal Medicine (2008)
Medical Education: Johns Hopkins University School of Medicine (2005)
Undergraduate: Johns Hopkins University (2001) -
Joo Ha Hwang, MD, PhD
Professor of Medicine (Gastroenterology and Hepatology) and, by courtesy, of Surgery
Current Research and Scholarly InterestsSpecialize in early detection of gastrointestinal malignancies including esophageal, gastric, pancreatic, bile duct & colon cancers. I have both a clinical & research interest in improving the early detection of gastric cancer in particular. I am the PI of the Gastric Precancerous conditions Study, a prospective study of patients with gastric intestinal metaplasia & other precancerous conditions which combines comprehensive clinical & endoscopic data with a large bio-specimen repository.
-
David Iberri
Clinical Assistant Professor, Medicine - Hematology
BioDr. Iberri is a hematologist who specializes in the treatment of multiple myeloma, Waldenström macroglobulinemia, and other blood and bone marrow disorders. He is actively involved in clinical research evaluating novel agents in hematologic malignancies. His research interests include the development and application of biomarkers to select patients most likely to benefit from therapy, and in the development of blood tests to reduce the need for bone marrow biopsies in myeloma disease monitoring.
-
Gentaro Ikeda
Instructor, Medicine - Cardiovascular Medicine
BioDr. Ikeda is a physician-scientist who develops innovative diagnostic and therapeutic modalities for patients with cardiovascular disease. Based on his clinical experience as a cardiologist, he has become aware of major clinical shortcomings, specifically in the current pharmaceutical therapies for myocardial infarction (MI) and chronic heart failure (HF). Some evidence-based drug therapies, including β-blockers, ivabradine, and renin-angiotensin-aldosterone antagonists are difficult to apply to critical patients due to adverse side effects. Drugs that have shown efficacy in basic animal experiments have failed to show significant benefits in clinical trials. To address these problems, he moved to academia to conduct translational research. During his graduate training in the Egashira Lab, he focused on drug delivery systems (DDS) that target mitochondria in animal models of MI. He obtained advanced skills in molecular biology, mitochondrial bioenergetics, and animal surgery. He realized the importance of translational research and the great potential of DDS to overcome many clinical problems. He developed nanoparticle-mediated DDS containing cyclosporine for the treatment of patients with MI. He published a first-author paper and received academic awards for his novel science. Since becoming a postdoctoral fellow in the Yang Lab, he has continued to build upon his previous training in translational research. He is currently developing an innovative therapy, namely, extracellular vesicles-mediated mitochondrial transfer for mitochondria-related diseases such as heart failure and mitochondrial disease.
-
Fumiaki Ikeno
Program Director (U.S) Japan Biodesign, Stanford Biodesign, Medicine - Med/Cardiovascular Medicine
BioProgram Director (U.S) Japan Biodesign, Stanford Biodesign
Researcher Cardiovascular Medicine, Stanford University
Faculty of Japan Reach, CARE (Center for Asian Health Research and Education) , Stanford University
Co-Director of Asia, SPARK Global, Stanford SPARK , Stanford University
Dr. Ikeno is a Researcher, Cardiovascular Medicine, Stanford University. In this role, he is responsible for pre clinical studies including GLP for medical devices and also regenerative medicines for cardiovascular diseases. Currently, he is devoting himself to the international regulatory project between Japan and the United States, also known as "Harmonization by Doing", whose focus is to collaborate with regulatory agencies such as FDA, PMDA/MHLW, academia and industries for improving the regulatory process in the 2 largest medtech markets. Dr. Ikeno also devoted himself to found Japan biodesign program which is a collaborative program with University of Tokyo, Osaka University, Tohoku University, Japan Federation Medical Device Association, Ministry of Education Japan and Stanford biodesign program. Currently, Dr. Ikeno serves as the Program Director (US) for Japan Biodesign. Dr. Ikeno is co-founder and board member of US-Japan MedTech Frontier which is a non-profit cooperate to make a trans-pacific eco-system of medical device between Japan and USA.
After 9 years clinical practice as an interventional cardiologist and Family Doctor in rural areas of Japan, Dr. Ikeno came to Stanford as a Researcher and completed his Biodesign Certificate Program. Being part of the ecosystem in Silicon Valley, Dr. Ikeno participated in more than 200 medtech projects and 50 GLP studies as well as in the analysis of clinical trials for cardiovascular medicine (BARI2D, FAME, ReOPEN etc). His other academic consortium projects include Peripheral Academic Research Consortium, Global Consensus Working Group of Optical Coherence Tomography, and Japan-US consensus document for the treatment of critical limb ischemia.
Over the last decade, Dr. Ikeno has served as an advisor for medical device industries and currently serves as a chief medical officer of an incubation fund specific for medtech (Medventure Partners, Inc, Tokyo) as a spin-off from Innovation Network Corporation of Japan (INCJ) that is the largest government and private partnership fund in Japan. He is also serving as a chair of cardiovascular working group of APAN (Asian Pacific Advanced Network) that contributes the remote education, research activities, and tele-health using a specialized internet network. Dr.Ikeno is also serving as consulting faculty/lecturer roles in several universities in Japan including University of Tokyo, Osaka University, Tsukuba University etc. Dr. Ikeno has authored over 70 peer reviewed publications and textbooks and has been invited to lecture at international medical conferences. Dr. Ikeno is a council member of U.S.- Japan Council which is a non-profit organization by Japanese American. He is serving as a mentor for START-X MED which is an accelerating program for Stanford related entrepreneurs in medical fields.
Contact Information
Falk CVRC CV007
300 Pasteur Drive
Palo Alto, CA 94305-5406 -
Hiroyuki Inoue
Postdoctoral Scholar, Cardiovascular Medicine
BioDr. Inoue is a physician-scientist who is enthusiastic about bridging research findings and clinical practice.
- a board certified cardiologist with 10+ years clinical experience
- experience in 400+ cases as a main operator in percutaneous coronary intervention, catheter ablation, and cardiac device implantation
- research expertise primarily in iPSCs, genome editing, and regenerative medicine
Dr. Inoue joined the Yang lab in 2022. His research aim is the development of novel regenerative therapeutics for heart failure. -
John P.A. Ioannidis
Professor of Medicine (Stanford Prevention Research), of Epidemiology and Population Health and by courtesy of Biomedical Data Science
Current Research and Scholarly InterestsMeta-research
Evidence-based medicine
Clinical and molecular epidemiology
Human genome epidemiology
Research design
Reporting of research
Empirical evaluation of bias in research
Randomized trials
Statistical methods and modeling
Meta-analysis and large-scale evidence
Prognosis, predictive, personalized, precision medicine and health
Sociology of science -
Eric Ip
Clinical Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly InterestsMy research interests include the use and abuse of anabolic steroids and other performance enhancing/cognitive enhancing drugs.
-
Haruka Itakura, MD, PhD
Assistant Professor of Medicine (Oncology)
BioDr. Haruka Itakura is an Assistant Professor of Medicine (Oncology) in the Stanford University School of Medicine, a data scientist, and a practicing breast medical oncologist at the Stanford Women’s Cancer Center. She is board-certified in Oncology, Clinical Informatics, Hematology, and Internal Medicine. Her research mission is to drive medical advances at the intersection of cancer and data science, applying state-of-the-art machine learning/artificial intelligence techniques to extract clinically actionable knowledge from heterogeneous multi-scale cancer data to improve patient outcomes. Her ongoing research to develop robust methodologies and apply cutting-edge techniques to analyze complex cancer big data was catapulted by an NIH K01 Career Development Award in Biomedical Big Data Science after obtaining a PhD in Biomedical Informatics at Stanford University. Her cancer research focuses on extracting radiomic (pixel-level quantitative imaging) features of tumors from medical imaging studies and applying machine learning frameworks, including radiogenomic approaches, for the integrative analysis of heterogeneous, multi-omic (e.g., radiomic, genomic, transcriptomic) data to accelerate discoveries in cancer diagnostics and therapeutics. Her current projects include prediction modeling of survival, treatment response, recurrence, and CNS metastasis in different cancer subtypes; detection of occult invasive breast cancer; and identification of novel therapeutic targets. Her ultimate goal is to be able to translate her research findings back to the clinical setting for the benefit of patients with difficult-to-treat cancers.
-
Charlotte D. Jacobs M.D.
Drs. Ben and A. Jess Shenson Professor in the School of Medicine, Emerita
Current Research and Scholarly InterestsClinical Interests: general oncology, sarcomas. Research Interests: clinical trials in solid tumors.
-
Karen Blake Jacobson
Adjunct Clinical Assistant Professor, Medicine
BioDr. Jacobson is Postdoctoral Medical Fellow in the Division of Infectious Diseases and Geographic Medicine. She previously received her MD and MPH from Icahn School of Medicine at Mount Sinai and completed residency in Internal Medicine/HIV Primary Care at Yale. She is board certified in Internal Medicine and Infectious Diseases. Dr. Jacobson’s current research focus is on the epidemiology and natural history of SARS-CoV-2, and the interactions between SARS-CoV-2 and malaria in pregnancy in malaria endemic settings.
-
Prasanna Jagannathan
Assistant Professor of Medicine (Infectious Diseases) and of Microbiology and Immunology
BioI am an Infectious Diseases physician-scientist with a research program in human immunology of malaria and clinical trials of immune modulatory interventions. Our group has been conducting detailed longitudinal cohort studies in children and pregnant women in order to study how repeated malaria shapes the cellular immune response. We are also studying how malaria control interventions such as antimalarial chemoprevention and vector control shape the acquisition and/or maintenance of protective immunity to malaria. We have expanded this work to not only include studying the mechanisms driving naturally acquired immunity to malaria, but other infectious diseases, including SARS CoV-2. We have also lead and/or participated in studies evaluating therapeutic strategies for patients with mild to moderate COVID-19.
-
Fereshteh Jahanbani
Basic Life Research Scientist, Medicine - Med/Immunology & Rheumatology
BioDr. Jahanbani received her PharmD from Tehran University of Medical Sciences (TUMS) and PhD in pharmacology from Iran University of Medical Sciences (IUMS) and her postdoctoral degree from Case Western Reserve University (CWRU) and University of California, Santa Cruz (UCSC). She joined Stanford Center for Genomics and Personalized Medicine in June 2012. Her work is focused on better understanding the etiology of chronic complex conditions and multi-morbidity using multi-omics and precision health approaches. She has been leading ME/CFS related disorders multi-omics study combining the power of both family and population approaches and also cofounded “Research To The People at Stanford Program”.
-
Prachee Jain
Postdoctoral Scholar, General Internal Medicine
Current Research and Scholarly InterestsIn her research, Prachee Jain is studying the design and implementation processes of intelligent technologies, such as AI-enabled robots, conversational agents and virtual assistants, and how they affect the interactions between humans in teams.
-
Sajid Jalil
Clinical Associate Professor, Medicine - Gastroenterology & Hepatology
BioDr. Jalil is a board-certified, fellowship-trained transplant hepatologist (liver doctor) and gastroenterologist at the Stanford Health Care Digestive Health Center in San Jose, California. He is also a clinical associate professor in the Department of Medicine, Division of Gastroenterology and Hepatology, at Stanford University School of Medicine.
Dr. Jalil has extensive experience helping patients with a range of liver- and digestion-related conditions. He specializes in liver transplantation, and his other clinical interests include all forms of hepatitis, cirrhosis of the liver, fatty liver disease, polycystic liver disease, and primary sclerosing cholangitis (swelling and scarring of the bile ducts). He has also volunteered in initiatives to offer free colonoscopy and hepatitis B screenings to underserved ethnic populations.
His research interests include improving mental health by enhancing treatment access for patients with alcohol use disorder causing alcoholic liver disease. He has also studied swallowing problems, liver disease in pregnancy, living liver donation, and the use of artificial intelligence in treating nonalcoholic fatty liver disease and viral hepatitis. In addition, Dr. Jalil wrote a chapter on bile secretion and cholestasis (diminished bile flow) for the fifth edition of Yamada’s Textbook of Gastroenterology.
Dr. Jalil has published in numerous peer-reviewed journals, including World Journal of Hepatology, Liver Transplantation, and the Journal of Clinical Gastroenterology. Additionally, he has served as a reviewer for Pancreatology and as an abstract reviewer for the American Gastroenterological Association (AGA) and the Ohio Chapter of the American College of Physicians. He has presented his research at meetings and conferences worldwide on a range of topics, including the timing of pregnancy after liver transplantation.
Dr. Jalil is an AGA fellow and a member of the American Association for the Study of Liver Diseases, American College of Gastroenterology, and American Society for Gastrointestinal Endoscopy. -
Mehrnaz Nicole Jamali MD
Clinical Associate Professor, Medicine - Cardiovascular Medicine
BioDr. M. Nicole Jamali focus has been in leadership, scientific innovation and streamlining business ventures. Over the past 20 years since graduation from Stanford Internal Medicine Residency, she has held National Positions in AMA as Western Caucus Chair and Appointee to Joint Commission Board. She was reelected to Board of Joint Commission three terms for total of 9 years. She helped rewrite multiple TJC Standards including creation of the Stroke Center of excellence standards and annual "new ideas section of the board". At AMA she authored and passed multiple House rules on variety of subjects affecting thousands of providers and healthcare centers. Her experiences in private practice, group practice, Hospitalist, Insurance Directorship lead to multiple innovative projects including first e-prescription covering both meds and DME in 1999 titled eRemedy,. She then created the first wrong site surgery device which was patented. This project lead to creation of first Transplant App called TPOD which was then simplified to TAPP. It was beta tested in USC and perfected in UCSF Transplant.
Her work with various Insurance companies resulted in streamlined programs and teaching modules improving patient access to health care and millions of dollars in hospital savings of unnecessary admissions.
Her work in creation and streamlining and connecting with local Primary Care providers resulted in rapid expansion of the Hospitalist program of local Hospital by 300%
She is currently interested in Haptic and AI technologies in Medicine and providing 24/7 care to our veterans in remote locations or even the battlefield.
She is currently Clinical Associated Professor and the lead Hospitalist in the new Stanford Cardiovascular Hospitalist Program and enjoys the daily interaction with patients . She truly believes that her mission in life is to be at the bedside of ill patients. She treats them as one of her own family. It is not atypical for her to hand out her personal phone number to make sure they feel safe even when discharged. -
Mathangi Janakiraman
Postdoctoral Scholar, Gastroenterology
Current Research and Scholarly InterestsAs a postdoctoral scholar, I am studying the gut ecosystem, gut functionality nad neuroimmune interactions during aging and age-associated diseases like AD, and the role of fermented food in modulating gut health. I expect to be able to show that dietary modifications can help with healthy aging and to contribute to possibly leveraging dietary interventions therapeutically in age-associated diseases.